Le Gjerum

504 citations

24 papers · 279 indexed · h-index 7

Impact in

Immunology and Allergy top 10%
- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research
Dermatology top 10%
- Dermatology and Skin Diseases

Papers in ⓘ

Dermatology 14
- Dermatology and Skin Diseases 14
Physiology 12
- Asthma and respiratory diseases 7
- Alzheimer's disease research and treatments 4

Co-authors: Kristian Steen Frederiksen (10 shared papers)Steen Gregers Hasselbalch (10 shared papers)Gunhild Waldemar (1 shared paper)Gunhild Waldemar (5 shared papers)Juha Koikkalainen (4 shared papers)Jyrki Lötjönen (5 shared papers)Marie Bruun (6 shared papers)Marta Baroni (4 shared papers)
Journals: British Journal of Dermatology (5 papers)NeuroImage Clinical (2 papers)Journal of Alzheimer s Disease (2 papers)Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (1 paper)PLoS ONE (1 paper)
Partner nations: Denmark United Kingdom Italy

In The Last Decade

Le Gjerum

18 papers receiving 272 citations

Peers

Countries citing papers authored by Le Gjerum

Since Specialization

Citations

This map shows the geographic impact of Le Gjerum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Gjerum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Gjerum more than expected).

Fields of papers citing papers by Le Gjerum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Le Gjerum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Gjerum. The network helps show where Le Gjerum may publish in the future.

Co-authors

The 25 scholars most cited alongside Le Gjerum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Le Gjerum Line = papers co-authored together Le Gjerum links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Effects of Physical Exercise on Alzheimer’s Disease Biomarkers: A Systematic Review of Intervention Studies Journal of Alzheimer s Disease ·Kristian Steen Frederiksen, Le Gjerum, Gunhild Waldemar, Steen Gregers Hasselbalch	2017	64
2	Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial Journal of the American Academy of Dermatology ·Andrew Blauvelt, Richard G. Langley, J.‐P. Lacour, Darryl Toth, Vivian Laquer, Stefan Beissert, Andreas Wollenberg, Pedro Herranz, Andrew Pink, Ketty Peris, Stine Fangel, Le Gjerum, Joshua Corriveau, Hidehisa Saeki, Richard B. Warren, Eric L. Simpson, Kristian Reich	2022	48
3	Detecting frontotemporal dementia syndromes using MRI biomarkers NeuroImage Clinical ·Marie Bruun, Juha Koikkalainen, Hanneke Rhodius‐Meester, Marta Baroni, Le Gjerum, Mark van Gils, Hilkka Soininen, Anne M. Remes, Päivi Hartikainen, Gunhild Waldemar, Patrizia Mecocci, Frederik Barkhof, Yolande A.L. Pijnenburg, Wiesje M. van der Flier, Steen Gregers Hasselbalch, Jyrki Lötjönen, Kristian Steen Frederiksen	2019	44
4	Physical Activity as a Moderator of Alzheimer Pathology: A Systematic Review of Observational Studies Current Alzheimer Research ·Kristian Steen Frederiksen, Le Gjerum, Gunhild Waldemar, Steen Gregers Hasselbalch	2019	31
5	Evaluating combinations of diagnostic tests to discriminate different dementia types Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring ·Marie Bruun, Hanneke Rhodius‐Meester, Juha Koikkalainen, Marta Baroni, Le Gjerum, Afina W. Lemstra, Frederik Barkhof, Anne M. Remes, Timo Urhemaa, Antti Tolonen, Daniel Rueckert, Mark van Gils, Kristian Steen Frederiksen, Gunhild Waldemar, Philip Scheltens, Patrizia Mecocci, Hilkka Soininen, Jyrki Lötjönen, Steen Gregers Hasselbalch, Wiesje M. van der Flier	2018	22
6	A visual rating scale for cingulate island sign on 18F-FDG-PET to differentiate dementia with Lewy bodies and Alzheimer's disease Journal of the Neurological Sciences ·Le Gjerum, Kristian Steen Frederiksen, Otto Mølby Henriksen, Ian Law, Lasse Anderberg, Birgitte Andersen, Eva Bjerregaard, Anne‐Mette Hejl, Peter Høgh, Steen Gregers Hasselbalch	2019	16
7	Evaluating 2-[18F]FDG-PET in differential diagnosis of dementia using a data-driven decision model NeuroImage Clinical ·Le Gjerum, Kristian Steen Frederiksen, Otto Mølby Henriksen, Ian Law, Marie Bruun, Anja Hviid Simonsen, Patrizia Mecocci, Marta Baroni, Massimo E. Dottorini, Juha Koikkalainen, Jyrki Lötjönen, Steen Gregers Hasselbalch	2020	13
8	Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years American Journal of Clinical Dermatology ·Raj Chovatiya, Simone Ribero, Andreas Wollenberg, Chang Ook Park, Juan Francisco Silvestre, Hwanhee Hong, Julien Sénéschal, Hidehisa Saeki, Jacob P. Thyssen, Christian Bjerregård Øland, Le Gjerum, Douglas Maslin, Andrew Blauvelt	2025	6
9	Comparing a Single Clinician Versus a Multidisciplinary Consensus Conference Approach for Dementia Diagnostics Journal of Alzheimer s Disease ·Gorm Thorlacius-Ussing, Marie Bruun, Le Gjerum, Kristian Steen Frederiksen, Hanneke Rhodius‐Meester, Wiesje M. van der Flier, Gunhild Waldemar, Steen Gregers Hasselbalch	2021	6
10	Comparison of the clinical impact of 2-[18F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer’s disease PLoS ONE ·Le Gjerum, Birgitte Andersen, Marie Bruun, Anja Hviid Simonsen, Otto Mølby Henriksen, Ian Law, Steen Gregers Hasselbalch, Kristian Steen Frederiksen	2021	6
11	Prognostic value of complementary biomarkers of neurodegeneration in a mixed memory clinic cohort PeerJ ·Mathias Holsey Gramkow, Le Gjerum, Juha Koikkalainen, Jyrki Lötjönen, Ian Law, Steen Gregers Hasselbalch, Gunhild Waldemar, Kristian Steen Frederiksen	2020	6
12	Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab JAMA Dermatology ·Andrew Blauvelt, Andrew Pink, Margitta Worm, Richard G. Langley, Boni E. Elewski, Le Gjerum, Emma Guttman‐Yassky	2022	5
13	Safety of Tralokinumab for the Treatment of Atopic Dermatitis in Patients with Up to 4.5 Years of Treatment: An Updated Integrated Analysis of Eight Clinical Trials SKIN The Journal of Cutaneous Medicine ·Kristian Reich, Richard G. Langley, Juan Francisco Silvestre, D. Staumont‐Sallé, Antonio Costanzo, Andrew Pink, Amy S. Paller, Norito Katoh, Andreas Wollenberg, Richard B. Warren, Christian Bjerregård Øland, Ann‐Marie Tindberg, Le Gjerum, Eric L. Simpson	2024	2
14	551 - Continuous tralokinumab treatment over 4 years in adults with moderate-to-severe atopic dermatitis provides long-term disease control British Journal of Dermatology ·Andrew Blauvelt, Richard G. Langley, Ketty Peris, Juan Francisco Silvestre, Norito Katoh, M. Tauber, Andreas Pinter, Mahreen Ameen, Melinda Gooderham, Christian Bjerregård Øland, Ann‐Marie Tindberg, Le Gjerum, Kristian Reich	2024	2
15	649 - Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials British Journal of Dermatology ·Kristian Reich, Richard G. Langley, Juan Francisco Silvestre, D. Staumont‐Sallé, Antonio Costanzo, Andrew Pink, Amy S. Paller, Norito Katoh, Andreas Wollenberg, Richard B. Warren, Christian Bjerregård Øland, Ann‐Marie Tindberg, Le Gjerum, Eric L. Simpson	2024	2
16	Tralokinumab demonstrated a consistent safety profile with up to 42 months of treatment in moderate-to-severe atopic dermatitis: including adverse events of special interest SKIN The Journal of Cutaneous Medicine ·Kristian Reich, Eric L. Simpson, Richard G. Langley, Richard B. Warren, Antonio Costanzo, Hidehisa Saeki, Peter Almgren, Le Gjerum, Anna Carlsson, Melinda Gooderham, Andreas Pinter, Marjolein de Bruin‐Weller, Andrew Blauvelt	2022	2
17	Tralokinumab demonstrated a consistent safety profile with up to 42 months of treatment in moderate to severe atopic dermatitis: including adverse events of special interest SKIN The Journal of Cutaneous Medicine ·Kristian Reich, Eric L. Simpson, Richard G. Langley, Richard B. Warren, Antonio Costanzo, Hidehisa Saeki, Peter Almgren, Le Gjerum, Anna Carlsson, Melinda Gooderham, Andreas Pinter, Marjolein De Bruin Weller, Andrew Blauvelt	2023	1
18	555 - Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials British Journal of Dermatology ·Kristian Reich, Richard G. Langley, Juan Francisco Silvestre, D. Staumont‐Sallé, Antonio Costanzo, Andrew Pink, Amy S. Paller, Norito Katoh, Andreas Wollenberg, Richard B. Warren, Christian Bjerregård Øland, Ann‐Marie Tindberg, Le Gjerum, Eric L. Simpson	2024	1
19	650 - Stability of long-term therapeutic responses to tralokinumab in adults with moderate-to-severe atopic dermatitis British Journal of Dermatology ·Andrew Blauvelt, Hwanhee Hong, Ketty Peris, Norito Katoh, M. Tauber, Mahreen Ameen, Melinda Gooderham, Christian Bjerregård Øland, Ann‐Marie Tindberg, Le Gjerum, Kristian Reich	2024	1
20	[P1–375]: DATA‐DRIVEN DIAGNOSIS OF DEMENTIA DISORDERS: THE PREDICTND VALIDATION STUDY Alzheimer s & Dementia ·Marie Bruun, Le Gjerum, Kristian Steen Frederiksen, Hanneke Rhodius‐Meester, Marta Baroni, Evelien Lemstra, Jonne A.E. Bremer, Anne M. Remes, Timo Urhemaa, Antti Tolonen, Tong Tong, Ricardo Guerrero, Daniel Rueckert, Gunhild Waldemar, Hilkka Soininen, Wiesje M. van der Flier, Patrizia Mecocci, Jyrki Lötjönen, Steen Gregers Hasselbalch	2017	1

About Le Gjerum

Le Gjerum is a scholar working on Dermatology, Physiology, Immunology and Allergy, Psychiatry and Mental health and Rheumatology, having authored 24 papers that have together received 279 indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (14 papers), Dementia and Cognitive Impairment Research (10 papers), Food Allergy and Anaphylaxis Research (8 papers), Asthma and respiratory diseases (7 papers), Allergic Rhinitis and Sensitization (5 papers), Alzheimer's disease research and treatments (4 papers), Urticaria and Related Conditions (3 papers) and Transgenic Plants and Applications (2 papers). The work is most often cited by research in Immunology and Allergy (57 citations), Dermatology (67 citations), Psychiatry and Mental health (103 citations), Neurology (42 citations) and Biological Psychiatry (11 citations). Le Gjerum has collaborated with scholars based in Denmark, United Kingdom and Italy. Frequent co-authors include Kristian Steen Frederiksen, Steen Gregers Hasselbalch, Gunhild Waldemar, Gunhild Waldemar, Juha Koikkalainen, Jyrki Lötjönen, Marie Bruun, Marta Baroni, Patrizia Mecocci and Kristian Reich. Their work appears in journals such as British Journal of Dermatology, NeuroImage Clinical, Journal of Alzheimer s Disease, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact